Mark Kemp

Mark Kemp is an accomplished medicinal chemist currently serving as Executive Director of Medicinal Chemistry at Centessa Pharmaceuticals, a role initiated in December 2024, focusing on developing innovative therapies for sleep-wake disorders. Previously, Mark held the position of VP Chemistry at Mission Therapeutics from December 2011 to October 2024, where responsibilities included establishing proprietary chemistry for inhibiting deubiquitinating enzymes and expanding the department significantly. Earlier experiences include a Senior Analyst role at Datamonitor in 2011, leading medicinal chemistry teams at Pfizer from 1994 to 2011, and completing a PhD in Chemistry at the University of Southampton. Mark's academic background includes obtaining a first-class BSc and a PhD in Chemistry, bolstered by an industrial placement at GSK.